Peng, Cheng <br/><br/>
Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.  [electronic resource] 

 -  Scientific reports  Feb 2016 
 - 20500 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep20500  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Colonic Neoplasms--drug therapy<br/>Dose-Response Relationship, Drug<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HT29 Cells<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Proto-Oncogene Protein c-ets-1--genetics